- Home
- VCEL vs PEBO Comparison
VCEL vs PEBO Comparison
Compare VCEL & PEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- PEBO
- Stock Information
- Founded
- VCEL 1989
- PEBO 1902
- Country
- VCEL United States
- PEBO United States
- Employees
- VCEL N/A
- PEBO N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- PEBO Major Banks
- Sector
- VCEL Health Care
- PEBO Finance
- Exchange
- VCEL Nasdaq
- PEBO Nasdaq
- Market Cap
- VCEL 2.1B
- PEBO N/A
- IPO Year
- VCEL 1997
- PEBO N/A
- Fundamental
- Price
- VCEL $40.15
- PEBO $32.10
- Analyst Decision
- VCEL Strong Buy
- PEBO Buy
- Analyst Count
- VCEL 8
- PEBO 6
- Target Price
- VCEL $62.00
- PEBO $36.67
- AVG Volume (30 Days)
- VCEL 423.4K
- PEBO 159.5K
- Earning Date
- VCEL 07-31-2025
- PEBO 07-22-2025
- Dividend Yield
- VCEL N/A
- PEBO 5.11%
- EPS Growth
- VCEL 521.85
- PEBO N/A
- EPS
- VCEL 0.05
- PEBO 3.15
- Revenue
- VCEL $238,541,000.00
- PEBO $561,241,000.00
- Revenue This Year
- VCEL $23.03
- PEBO N/A
- Revenue Next Year
- VCEL $24.52
- PEBO $3.67
- P/E Ratio
- VCEL $803.09
- PEBO $10.19
- Revenue Growth
- VCEL 14.80
- PEBO 12.39
- 52 Week Low
- VCEL $37.39
- PEBO $26.21
- 52 Week High
- VCEL $63.00
- PEBO $37.07
- Technical
- Relative Strength Index (RSI)
- VCEL 44.33
- PEBO 72.10
- Support Level
- VCEL $40.53
- PEBO $30.37
- Resistance Level
- VCEL $43.57
- PEBO $30.41
- Average True Range (ATR)
- VCEL 1.62
- PEBO 0.64
- MACD
- VCEL -0.16
- PEBO 0.28
- Stochastic Oscillator
- VCEL 28.65
- PEBO 94.41
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.